1802 CAPSTONE: an observational retrospective analysis comparing a complement activation multianalyt...
1802 CAPSTONE: an observational retrospective analysis comparing a complement activation multianalyte panel vs. Standard ANA testing: systemic lupus erythematosus diagnosis, treatment outcomes and economic impact
About this item
Full title
Author / Creator
Publisher
London: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
London: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
BackgroundSystemic Lupus Erythematosus (SLE) is a complex clinical disease that often takes years and repeated testing to adequately diagnose. Standard biomarkers have low specificity (ANA) or low sensitivity (anti-dsDNA, anti-Smith). The advent of a multianalyte assay panel (MAP) incorporating innovative cell-bound complement activation markers wa...
Alternative Titles
Full title
1802 CAPSTONE: an observational retrospective analysis comparing a complement activation multianalyte panel vs. Standard ANA testing: systemic lupus erythematosus diagnosis, treatment outcomes and economic impact
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7ae122f3fa7849d79746b87974e51e55
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7ae122f3fa7849d79746b87974e51e55
Other Identifiers
E-ISSN
2053-8790
DOI
10.1136/lupus-2022-lupus21century.103
